
The Fellow on Call: The Heme/Onc Podcast
We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physicians.
Latest episodes

Jun 25, 2025 • 0sec
Episode 137: Follicular Lymphoma Series, Pt 2. - Front-line Management
This discussion dives deep into front-line therapies for follicular lymphoma. It unpacks management strategies for both localized and diffuse disease, assessing treatment options for symptomatic versus asymptomatic patients. The impact of rituximab therapy is evaluated, with insights from the PRIMA trial. The conversation also highlights the evolving understanding of lymphoma classifications and the role of personalized care in improving patient outcomes. Historical studies shape today's decisions, making it a compelling exploration of treatment approaches.

May 21, 2025 • 0sec
Episode 136: Follicular Lymphoma Series, Pt. 1 - Introduction
Explore the challenges of managing follicular lymphoma as the hosts discuss accurate biopsy techniques and the importance of tissue sampling. Discover the nuances of diagnosing various lymphoma types, particularly focusing on CD10 positivity. Delve into the classification of follicular lymphoma subtypes, including rare variants and their treatment implications. The discussion also highlights the significance of imaging techniques like PET-CT scans and effective staging systems that are critical for tailored treatment strategies.

May 7, 2025 • 0sec
Episode 135: VTE Series - Management of Antiphospholipid Antibody Syndrome
Delve into the management of antiphospholipid antibody syndrome with insights on anticoagulants. Discover if a higher INR is indeed better for warfarin and explore the role of Direct Oral Anticoagulants. The hosts debate the optimal timing for APLS testing—don't miss their lively back-and-forth! A recent trial sheds light on transitioning patients from warfarin to rivaroxaban, scrutinizing its findings. Plus, learn about the comparative effects of apixaban and warfarin in this complex treatment landscape.

Apr 23, 2025 • 0sec
Episode 134: VTE Series - Diagnosis of Antiphospholipid Antibody Syndrome
This week, the focus is on antiphospholipid antibody syndrome and its connection to venous thromboembolism. The hosts discuss the complexities of diagnosis, including the significance of specific antibody tests and the common pitfalls of false positives. A real-life case study highlights the clinical criteria necessary for accurate assessment and management. Listeners gain insights into the evolution of the syndrome's understanding and the implications for effective patient care, especially in pregnancy.

Apr 9, 2025 • 0sec
Episode 133: VTE Series - Perioperative Anticoagulation Management and Emergent Reversal
Delve into the crucial considerations of managing anticoagulation during surgeries and emergencies. Learn the importance of holding and reversing anticoagulants in various clinical scenarios. The discussion emphasizes effective communication with patients and healthcare providers to ensure safety. Discover insights on using Indexanet alpha as a reversal agent and the complexities involved in individual patient care. This informative session balances technical expertise with relatable anecdotes, making it a must-listen for medical professionals.

Apr 2, 2025 • 0sec
Episode 132: VTE Series- Approach to Hypercoagulable/Thrombophilia Testing
This week, we talk all about hypercoagulable testing - a very common referral in outpatient hematology. Who do we consider testing on? Who should we encourage not to test? We discuss this and more here. Episode contents:- What are situations in which to consider hypercoaguable testing? - What are situations to avoid doing so? **** Get paid to participate in market research surveys: https://affiliatepanel.members-only.online/FOC_24?utm_campaign=FOC&utm_source=email&utm_medium=email** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

Mar 26, 2025 • 0sec
Episode 131: VTE Series-Approach to workup and initial management
Dive into the world of venous thromboembolism (VTE) as experts unravel the essentials of diagnosis and initial management. Discover the importance of accurate imaging and the collaborative efforts among medical specialties. Learn strategies for managing pulmonary embolism and deep vein thrombosis, including advanced imaging techniques and the role of IVC filters. Unpack the complexities of anticoagulation management and the risks associated with thrombolytics. Engage with patient risk factors that shape treatment decisions!

Mar 5, 2025 • 0sec
Episode 130: Testicular Cancer Series, Pt 4 - Role of Radiation Oncology
Dr. Amar Kishan, a radiation oncologist at UCLA, sheds light on the pivotal role of radiation therapy in testicular cancer treatment. He discusses essential studies needed before radiation appointments and the planning process for seminoma patients. Key concerns such as fertility, hormonal function, and the implications of radiation are addressed. The conversation also explores emerging therapies and the benefits of proton therapy, clarifying its advantages and aiming to minimize long-term health risks for younger patients.

Feb 12, 2025 • 0sec
Episode 129: Testicular Cancer Series, Pt 3 - Disseminated and relapsed/refractory disease
The discussion dives deep into disseminated testicular cancer and its treatment options. Personal anecdotes add warmth as speakers share insights on teamwork and recent experiences. A captivating case study highlights the significance of a multidisciplinary approach. The evolution of treatment regimens showcases remarkable advancements in cure rates. Innovative strategies for relapsed or refractory disease, including high-dose carboplatin, point to the future of patient care. Tune in for engaging insights and expert analysis!

Jan 29, 2025 • 0sec
Episode 128: Testicular Cancer Series, Pt 2 - Stage 1 and 2
Dive deep into the world of testicular cancer as the discussion highlights the nuances of treating Stage 1 and 2 diseases. Learn about effective management strategies, including chemotherapy, radiation, and surgery. The fascinating exploration of pivotal trials illuminates how they shape current treatments. Personal anecdotes and humor make the complex subject relatable while showcasing impressive survival rates, especially for Stage 1 seminoma. It's an insightful blend of medical expertise and engaging dialogue!